Inventor · disambiguated record
Wengen Wu
Also filed as: WU WENGEN
24 granted patents·16 pending applications·63 citations·filing 2005–2024
95Inventor score
Top patents by PatentIndex Score
40 records- 0196US11266669B2FAP-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2020·Granted Mar 8, 2022·4 cites·39 claims
- 0295US11957657B2Combination therapies using immuno-dash inhibitors and PGE2 antagonistsTUFTS COLLEGE·Filed 2021·Granted Apr 16, 2024·2 cites·17 claims
- 0395US11096924B2Combination therapies using immuno-dash inhibitors and PGE2 antagonistsTUFTS COLLEGE·Filed 2017·Granted Aug 24, 2021·6 cites·29 claims
- 0495US9737556B2FAP-activated therapeutic agents, and uses related theretoTUFTS COLLEGE·Filed 2015·Granted Aug 22, 2017·8 cites·8 claims
- 0594US10117887B2FAP-activated therapeutic agents, and uses related theretoTUFTS COLLEGE·Filed 2017·Granted Nov 6, 2018·6 cites·39 claims
- 0693US10709722B2FAP-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2018·Granted Jul 14, 2020·5 cites·33 claims
- 0791US11583516B2Dash inhibitors, and uses related theretoTUFTS COLLEGE·Filed 2017·Granted Feb 21, 2023·3 cites·18 claims
- 0889US12478609B2Combination therapies using immuno-DASH inhibitors and PGE2 antagonistsTUFTS COLLEGE·Filed 2024·Granted Nov 25, 2025·0 cites·18 claims
- 0989US8268880B2Soft protease inhibitors and pro-soft forms thereofBACHOVCHIN WILLIAM W·Filed 2006·Granted Sep 18, 2012·9 cites·16 claims
- 1088US10245248B2FAP-activated therapeutic agents, and uses related theretoTUFTS COLLEGE·Filed 2015·Granted Apr 2, 2019·5 cites·11 claims
- 1188US2025108031A1Fap-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 1287US2024398842A1Fap-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 1386US11559537B2Combination therapies using caspase-1 dependent anticancer agents and PGE2 antagonistsTUFTS COLLEGE·Filed 2018·Granted Jan 24, 2023·2 cites·24 claims
- 1486US8933056B2Soft protease inhibitors and pro-soft forms thereofTUFTS COLLEGE·Filed 2013·Granted Jan 13, 2015·5 cites·3 claims
- 1585US11033525B2Fap-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2019·Granted Jun 15, 2021·1 cites·12 claims
- 1683US2023390241A1Dash inhibitors, and uses related theretoTUFTS COLLEGE·Filed 2023·Application pending·0 cites
- 1780US11925655B2FAP-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2022·Granted Mar 12, 2024·0 cites·20 claims
- 1877US12053450B2FAP-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2021·Granted Aug 6, 2024·0 cites·17 claims
- 1976US12121505B2Fap-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2021·Granted Oct 22, 2024·0 cites·10 claims
- 2076US12023316B2FAP-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2021·Granted Jul 2, 2024·0 cites·20 claims
- 2174US8937063B2Niacin mimetics, and methods of use thereofBACHOVCHIN WILLIAM W·Filed 2011·Granted Jan 20, 2015·3 cites·29 claims
- 2273US9212142B2Niacin mimetics, and methods of use thereofTUFTS COLLEGE·Filed 2013·Granted Dec 15, 2015·2 cites·24 claims
- 2373US8450316B2Niacin mimetics, and methods of use thereofBACHOVCHIN WILLIAM W·Filed 2011·Granted May 28, 2013·2 cites·6 claims
- 2472US11707539B2FAP-targeted radiopharmaceuticals and imaging agents, and uses related theretoTUFTS COLLEGE·Filed 2021·Granted Jul 25, 2023·0 cites·22 claims
- 2572US2023330275A1Fap-targeted radiopharmaceuticals and imaging agents, and uses related theretoTUFTS COLLEGE·Filed 2022·Application pending·0 cites
- 2666US9192646B2Soft protease inhibitors and pro-soft forms thereofTUFTS COLLEGE·Filed 2014·Granted Nov 24, 2015·0 cites·17 claims
- 2766US2009062235A1Inhibitors of Dipeptidylpeptidase IVTUFTS COLLEGE·Filed 2008·Application pending·0 cites
- 2865US2024366807A1Radiofluorinated agents for pet imaging selectively targeting fibroblast activation proteinTUFTS COLLEGE·Filed 2022·Application pending·0 cites
- 2964US2023372372A1Combination therapies using caspase-1 dependent anticancer agents and pge2 antagonistsTUFTS COLLEGE·Filed 2023·Application pending·0 cites
- 3064US2024408408A1Fap-targeted neutron capture agents, and uses and formulations related theretoTUFTS COLLEGE·Filed 2022·Application pending·0 cites
- 3162US8563533B2Soft protease inhibitors and pro-soft forms thereofBACHOVCHIN WILLIAM W·Filed 2012·Granted Oct 22, 2013·0 cites·25 claims
- 3261US2024207292A1Boronic acid compounds, compositions and methodsTUFTS COLLEGE·Filed 2022·Application pending·0 cites
- 3360US2014018545A1Inhibitors of Dipeptidylpeptidase IVBACHOVCHIN WILLIAM W·Filed 2013·Application pending·0 cites
- 3460US2022211883A1Fap-activated radiotheranostics and uses related theretoTUFTS COLLEGE·Filed 2021·Application pending·0 cites
- 3557US2005203027A1Inhibitors of dipeptidylpeptidase IVTUFTS COLLEGE·Filed 2005·Application pending·0 cites
- 3656US2016250237A1Soft protease inhibitors and pro-soft forms thereofTUFTS COLLEGE·Filed 2015·Application pending·0 cites
- 3755US2011218142A1Inhibitors of Dipeptidylpeptidase IVTUFTS COLLEGE·Filed 2011·Application pending·0 cites
- 3851US2015094303A1Niacin Mimetics, and Methods of Use ThereofTUFTS COLLEGE·Filed 2014·Application pending·0 cites
- 3946US2016030441A1Niacin mimetics, and methods of use thereofTUFTS COLLEGE·Filed 2015·Application pending·0 cites
- 4045US8513187B2Soft protease inhibitors, and pro-soft forms thereofBACHOVCHIN WILLIAM W·Filed 2010·Granted Aug 20, 2013·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Wengen Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →